Uwe Reinhardt - Tekla Healthcare Insider

HQH -- USA Stock  

USD 22.21  0.33  1.51%

Independent Trustee

Dr. Uwe E. Reinhardt, Ph.D., is an Independent Trustee of HQ Healthcare Investors. Dr. Reinhardt is the James Madison Professor of Political Economy at Princeton University, teaching economics and public affairs since 1968, and was a member of the Institute of Medicine of the National Academy of Sciences since 1978. He serves on the Audit Committee of each Fund. Dr. Reinhardt is recognized as one of the nation leading authorities on health care economics, a prominent scholar in health care economics and a frequent speaker and author on subjects ranging from the war in Iraq to the future of Medicare. Dr. Reinhardt provides each Fund with valuable insights in healthcare economics and reform. He is a past president of the Association of Health Services Research. From 1986 to 1995 he served as a commissioner on the Physician Payment Review Committee, established in 1986 by Congress to advise it on issues related to the payment of physicians. He is a senior associate of the Judge Institute for Management of Cambridge University, UK, and a trustee of Duke University and the Duke University Health System. Dr. Reinhardt is or was a member of numerous editorial boards, among them the Journal of Health Economics, the Milbank Memorial Quarterly, Health Affairs, the New England Journal of Medicine, and the Journal of the American Medical Association
Age: 79  Executive Since 1988  Ph.D    
617-772-8500  http://www.teklacap.com/hqh.html
Reinhardt received his Ph.D. from Yale University.

Management Efficiency

The company has Return on Asset of (0.34) % which means that on every $100 spent on asset it lost $0.34. This is way below average. In the same way, it shows return on shareholders equity (ROE) of 10.22 % implying that it generated $10.22 on every 100 dollars invested.

Similar Executives

Entity Summary

Tekla Healthcare Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. Tekla Healthcare Investors was formed on October 31, 1986 and is domiciled in the United States. Tekla Healthcare operates under Closed-End Fund - Equity classification in USA and traded on New York Stock Exchange.Tekla Healthcare Investors (HQH) is traded on New York Stock Exchange in USA. It is located in 2 Liberty Square and employs 13 people.

Tekla Healthcare Inv Leadership Team

William Reardon, Executive, CPA
Michael Bonney, Executive
Oleg Pohotsky, Chairman, MBA
Laura Woodward, Executive, CPA
Lucinda Stebbins, Executive, CPA
Daniel Omstead, CEO
Uwe Reinhardt, Executive, Ph.D
Rakesh Jain, Executive

Stock Performance Indicators

Current Sentiment - HQH

Tekla Healthcare Inv Investor Sentiment
Greater number of Macroaxis users are currently bullish on Tekla Healthcare Investors. What is your outlook on investing in Tekla Healthcare Investors? Are you bullish or bearish?
98% Bullish
2% Bearish

Generate Optimal Portfolios

Align your risk and return expectations
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please also check Risk vs Return Analysis. Please also try Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.